CTOs on the Move


 
EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.eqrx.com
  • 50 Hampshire Street
    Cambridge, AK USA 02139
  • Phone: 617.315.2255

Executives

Name Title Contact Details

Funding

EQRx raised $200M on 01/12/2020
EQRx raised $500M on 01/11/2021

Similar Companies

Envision Communications

Envision Communications is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Brogan Pharmaceuticals

Brogan Pharmaceuticals is a Crown Point, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biocodex

Biocodex is a San Bruno, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Trimel Pharmaceuticals

Trimel Pharmaceuticals Corporation is a Canadian specialty pharmaceutical company focused on bringing innovative products to market that improve the patient experience and produce strong investor returns. The Corporation holds a licence for the development and marketing rights to certain products utilizing a bioadhesive intranasal gel drug delivery technology platform and owns a novel unit-dose dry powder inhaler/nasal dispersion system (“TriVair™”). The Corporation is focussing its present efforts on the development and application of these technologies for therapeutic categories such as (a) male hypogonadism (“low testosterone” or “Low-T”) and (b) female orgasmic disorder. Additionally, the Corporation owns the Canadian rights to ESTRACE® and is overseeing its distribution and marketing in Canada. The Corporation’s present drug delivery technology platforms are intended to create products that are expected to be innovative, safer, possibly more effective, easier to use and more practical than competitive products on the market.